ARX788, a Site-specific Anti-HER2 Antibody-Drug Conjugate, Demonstrates Potent and Selective Activity in HER2-low and T-DM1-resistant Breast and Gastric Cancers
ARX788 是一种位点特异性抗 HER2 抗体-药物偶联物，在 HER2 低和 T-DM1 耐药乳腺癌和胃癌中表现出强效和选择性活性
期刊:Molecular Cancer Therapeutics
影响因子:5.3
doi:10.1158/1535-7163.MCT-19-1004
Lillian Skidmore, Sukumar Sakamuri, Nick A Knudsen, Amha Gebre Hewet, Snezana Milutinovic, Wisam Barkho, Sandra Lyn Biroc, Jessica Kirtley, Robin Marsden, Kristine Storey, Ianina Lopez, Wayne Yu, Shiao-Yan Fang, Sulan Yao, Yi Gu, Feng Tian
